OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	193.07B
Revenue (ttm)	15.22B
Net Income (ttm)	399.52M
Shares Out	114.53M
EPS (ttm)	3.52
PE Ratio	483.25
Forward PE	35.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	197,170
Average Volume	179,104
Open	1,659.40
Previous Close	1,667.80
Day's Range	1,649.90 - 1,690.70
52-Week Range	1,209.95 - 2,248.00
Beta	n/a
RSI	48.48
Earnings Date	Feb 10, 2026

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,412
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In 2024, NSE:ONESOURCE's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2023.